Establishment and characterization of a new drug surviving cell line Am1010, derived directly from muscle metastases of a human lung adenocarcinoma patient with multi-drug-resistance to cisplatin, taxol, and gefitinib

類似資料

• Silibinin restores the sensitivity of cisplatin and taxol in A2780-resistant cell and reduces drug-induced hepatotoxicity
  著者:: Yang, Zhichun, 等
  出版事項: (2019)
• Recurrent response to advanced lung adenocarcinoma with erlotinib developing leptomeningeal metastases during gefitinib therapy and two case reports
  著者:: Xing, Puyuan, 等
  出版事項: (2014)
• Inhibition of DNA-PK by gefitinib causes synergism between gefitinib and cisplatin in NSCLC
  著者:: Pan, Chi, 等
  出版事項: (2020)
• Evaluation on efficacy and safety of the addition of X-knife therapy to gefitinib in NSCLC patients with symptomatic brain metastases
  著者:: Cai, Linbo, 等
  出版事項: (2016)
• Synergistic cytotoxicity of cisplatin and Taxol in overcoming Taxol resistance through the inhibition of LDHA in oral squamous cell carcinoma
  著者:: FENG, LIN, 等
  出版事項: (2015)